A microbiome perspective on metabolic diseases.
The gut microbiome is a critical mediator in the interaction between an individual and their nutritional environment. As such, it has great potential as a target for the prevention and treatment of diet-related metabolic diseases.

This talk reports recent large-scale, multi-omic studies of the gut microbiome in type 2 diabetes and non-alcoholic fatty liver disease. In doing so, it addresses the role of microbially-mediated inflammation in the onset and development of both diseases. It also highlights the challenges inherent in microbiome studies, where causality may be attributed at the level of a single species, a clade, or a complex community.
Date: 29 July 2019, 12:00 (Monday, 14th week, Trinity 2019)
Venue: Kennedy Institute of Rheumatology, Headington OX3 7FY
Venue Details: Bernard Sunley Lecture Theatre
Speaker: Dr Jethro Johnson (The Jackson Laboratory for Genomic Medicine, Connecticut)
Organising department: Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS)
Organisers: Jennifer Pope (Kennedy Institute of Rheumatology), Jo Silva (NDORMS)
Organiser contact email address: jennifer.pope@kennedy.ox.ac.uk
Host: Professor Fiona Powrie (Kennedy Institute of Rheumatlogy)
Part of: Kennedy Institute Seminars
Booking required?: Not required
Audience: Public
Editor: Jennifer Pope